pylori can be released from C
TB-500 peptide Studied in connective tissue models and cellular migration research
An additional three posters have been accepted to the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting 2026 in Miami (May 2629), featuring data from our Phase 2b trial in TRD (GH001-TRD-201), including the post-hoc analysis of efficacy by prior antidepressant failure, secondary endpoints covering anxiety and quality of life, and impact on anhedonia
Furthermore, several of the loci identified here overlap or fall near signals reported in prior global glaucoma GWAS, while others may reflect novel ancestry-specific contributions, reinforcing the value of expanding genomic studies in underrepresented populations
Researchers are interested in understanding how the peptide may influence cellular communication, collagen production, and tissue maintenance